Results 121 to 130 of about 20,470 (212)

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect

Dermatopathology
A 74-year-old woman in good general health presented with a 5-year history of progressive hair loss over several years, interpreted as female androgenetic alopecia (AGA), and was treated with topical 5% Minoxidil without improvement.
Carlo Francesco Tomasini, Giacomo Fiandrino, Emanuele Mario Favale, Francesca Antoci, Stefania Barruscotti   +4 more
doaj   +1 more source

Giant Basal Cell Carcinoma of the Lateral Neck: A Case Study. [PDF]

Cureus, 2023
Bryson AM, Dominiak N, Frank PW.
europepmc   +1 more source

Lupus Vulgaris in a Maltese patient [PDF]

, 2004
Introduction The incidence of cutaneous tuberculosis (TB) in the developed world has fallen, in parallel with the decline of other forms of TB. Nevertheless cases still occur and their diagnosis may be difficult.
Boffa, Michael J., Farrugia, Brian, DeGaetano, James   +2 more
core  

Atypical Fibroxanthoma/Pleomorphic Dermal Sarcoma With Osseous Metaplasia: A Series of Three Cases

Journal of Cutaneous Pathology, Volume 53, Issue 5, Page 407-413, May 2026.
ABSTRACT Atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) are rare mesenchymal tumors typically arising on sun‐damaged skin of the head and neck in elderly patients. PDS is a more aggressive tumor but with similar demographics, cellular morphology, immunohistochemical features, and genetic findings.
Taylor Novice, Yitong Xu, Thomas Brenn, Scott C. Bresler   +3 more
wiley   +1 more source

Giant Basal Cell Carcinoma Causing Axillary Contracture: A Case Report of an Unusual Localization of an Advanced Case. [PDF]

Ann Dermatol, 2023
Albayati A, Özkan B, Tepeoğlu M, Uysal ÇA.   +3 more
europepmc   +1 more source

Porous polyethylene in reconstructive head and neck surgery [PDF]

, 1985
Berghaus, Alexander
core   +1 more source

Clinical Features and Outcomes of Locally Advanced and Metastatic Basal Cell Carcinoma

Acta Dermato-Venereologica
Cutaneous basal cell carcinoma (BCC) is a primarily indolent tumour that is easily cured. However, locally advanced BCC (laBCC) and metastatic BCC can have a poor prognosis.
Anna A.J.H. Zwanenburg, Winan J. Van Houdt, A. Marjolein Schrijver, Willem H. Schreuder, Michel W. J. M. Wouters, Elsemieke I. Plasmeijer   +5 more
doaj   +1 more source

Epidermal growth factor receptor is a marker for syncytiotrophoblastic cells in testicular germ cell tumors [PDF]

, 2018
The epidermal growth factor receptor (EGFR) has been implicated in the pathogenesis, therapy and prognosis of various tumor types. The aim of this study was to investigate EGFR expression in a large series of testicular germ cell tumors (TGCTs).
Hechelhammer, Lukas, Heitz, Philipp, Jochum, Wolfram, Odermatt, Bernhard, Störkel, Stephan   +4 more
core  

Giant basal cell carcinoma of the vulva successfully treated with Sonidegib. [PDF]

Dermatol Ther, 2022
Camela E, Villani A, Scalvenzi M, Costa C.   +3 more
europepmc   +1 more source